United States · FDA National Drug Code directory
Theophylline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-026_0d340b17-907e-4c38-bbd6-c4740495a55a
- Product NDC
- 46708-026
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Theophylline
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20101101
- Source listing expiry
- 20261231
Source-listed ingredients
- THEOPHYLLINE ANHYDROUS — 450 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-026-30) · 46708-026-30
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-026-31) · 46708-026-31
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-026-71) · 46708-026-71
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →